EP
PAHC icon

Essential Partners’s Phibro Animal Health PAHC Stock Holding History

Essential Partners’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.45K Sell
78
-2
-3% -$84 ﹤0.01% 1893
2026
Q1 		$4.42K Hold
80
– – ﹤0.01% 1637
2025
Q4 		$2.99K Sell
80
-4
-5% -$162 ﹤0.01% 1646
2025
Q3 		$3.4K Buy
84
+29
+53% +$958 ﹤0.01% 1582
2025
Q2 		$1.41K Buy
+55
New +$1.2K ﹤0.01% 1419

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Essential Partners's PAHC Position: Q2 2026 in Review

Essential Partners reduced its Phibro Animal Health (PAHC) stake by 2.5% in Q2 2026, selling an estimated $84 and leaving 78 shares worth $2.45K. The position accounts for ﹤0.01% of the portfolio, ranked #1893.

Essential Partners first reported a position in PAHC in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.42K in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Essential Partners held 78 shares of Phibro Animal Health worth $2.45K as of Q2 2026.
  • Essential Partners sold 2 Phibro Animal Health shares in Q2 2026, an estimated $84.
  • Phibro Animal Health made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1893 holding.
  • Essential Partners first reported a position in Phibro Animal Health in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's Phibro Animal Health position peaked at $4.42K in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.